Related Experiment Video
Updated: Aug 9, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Association between Inflammatory Bowel Disease and Iridocyclitis: A Mendelian Randomization Study
Yang Meng1, Zongbiao Tan2, Chuan Liu2
1Department of Ophthalmology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan 430060, China.
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), increases the risk of iridocyclitis (IC). Crohn's disease shows a stronger association with IC, but IC does not increase the risk of IBD.
Area of Science:
- Ophthalmology
- Gastroenterology
- Genetics
Background:
- Iridocyclitis (IC) is a frequent extraintestinal manifestation of inflammatory bowel disease (IBD).
- Observational studies suggest links between ulcerative colitis (UC), Crohn's disease (CD), and IC, but causality is unclear.
Purpose of the Study:
- To investigate the causal relationship between IBD subtypes (UC and CD) and IC using a bidirectional Mendelian randomization approach.
- To determine the directionality of the association between IBD and IC.
Main Methods:
- Utilized genetic variants from genome-wide association studies and the FinnGen database as instrumental variables.
- Performed bidirectional and multivariable Mendelian randomization (MR) analyses, employing inverse-variance weighted (IVW), MR Egger, and weighted median methods.
- Conducted sensitivity analyses including MR-Egger intercept, MR-PRESSO, Cochran's Q test, and leave-one-out analysis to ensure robustness.
Main Results:
- Bidirectional MR indicated positive associations between both UC and CD with IC (acute, subacute, and chronic).
- Multivariable MR confirmed a stable association from Crohn's disease (CD) to iridocyclitis (IC).
- Reverse analysis showed no causal association from IC to UC or CD.
Conclusions:
- Both UC and CD are associated with an elevated risk of IC, with CD exhibiting a stronger association.
- IC does not appear to increase the risk of developing UC or CD.
- Ophthalmic screening is crucial for IBD patients, particularly those with CD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

